Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
研究单位：[1]Baxalta now part of Shire[2]Institute of Hematology and Oncology, Harbin The First Hospital[3]Institute of Hematology and Oncology, Harbin The First Hospital[4]Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology
研究目的：
The purpose of this post-marketing safety study is to evaluate the safety, immunogenicity, and effectiveness of ADVATE in previously untreated patients (PUPs) in China with moderate to severe hemophilia A.
